191 related articles for article (PubMed ID: 22100988)
1. Integrin expression during reverse remodeling in the myocardium of heart failure patients.
Dullens HF; Schipper ME; van Kuik J; Sohns W; Scheenstra M; van Wichen DF; Van Oosterhout MF; de Jonge N; de Weger RA
Cardiovasc Pathol; 2012; 21(4):291-8. PubMed ID: 22100988
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
4. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
6. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
7. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
Klotz S; Jan Danser AH; Burkhoff D
Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
[TBL] [Abstract][Full Text] [Related]
8. Molecular changes after left ventricular assist device support for heart failure.
Birks EJ
Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
[TBL] [Abstract][Full Text] [Related]
9. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
[TBL] [Abstract][Full Text] [Related]
10. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.
Orrego CM; Nasir N; Oliveira GH; Flores-Arredondo JH; Cordero-Reyes AM; Loebe M; Youker KA; Torre-Amione G
Congest Heart Fail; 2011; 17(3):140-6. PubMed ID: 21609388
[TBL] [Abstract][Full Text] [Related]
11. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
[TBL] [Abstract][Full Text] [Related]
12. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
Schipper ME; van Kuik J; de Jonge N; Dullens HF; de Weger RA
J Heart Lung Transplant; 2008 Dec; 27(12):1282-5. PubMed ID: 19059107
[TBL] [Abstract][Full Text] [Related]
13. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
14. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
[TBL] [Abstract][Full Text] [Related]
15. Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium.
Wohlschlaeger J; Sixt SU; Stoeppler T; Schmitz KJ; Levkau B; Tsagakis K; Vahlhaus C; Schmid C; Peters J; Schmid KW; Milting H; Baba HA
J Heart Lung Transplant; 2010 Jan; 29(1):125-32. PubMed ID: 19837610
[TBL] [Abstract][Full Text] [Related]
16. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
17. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
18. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
[TBL] [Abstract][Full Text] [Related]
19. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
[TBL] [Abstract][Full Text] [Related]
20. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
